Cargando…
Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients
Psoriasis (Ps) is an immune-mediated inflammatory skin disease that is widely associated with the clinical features of metabolic syndrome (MetS), including hypertension, abdominal obesity, insulin resistance, type 2 diabetes and dyslipidemia. Osteopontin (OPN), a multifunctional protein involved in...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918436/ https://www.ncbi.nlm.nih.gov/pubmed/33668559 http://dx.doi.org/10.3390/jcm10040755 |
_version_ | 1783657922086043648 |
---|---|
author | Bartosińska, Joanna Przepiórka-Kosińska, Joanna Sarecka-Hujar, Beata Raczkiewicz, Dorota Kowal, Małgorzata Chyl-Surdacka, Katarzyna Bartosiński, Jarosław Kosiński, Jakub Krasowska, Dorota Chodorowska, Grażyna |
author_facet | Bartosińska, Joanna Przepiórka-Kosińska, Joanna Sarecka-Hujar, Beata Raczkiewicz, Dorota Kowal, Małgorzata Chyl-Surdacka, Katarzyna Bartosiński, Jarosław Kosiński, Jakub Krasowska, Dorota Chodorowska, Grażyna |
author_sort | Bartosińska, Joanna |
collection | PubMed |
description | Psoriasis (Ps) is an immune-mediated inflammatory skin disease that is widely associated with the clinical features of metabolic syndrome (MetS), including hypertension, abdominal obesity, insulin resistance, type 2 diabetes and dyslipidemia. Osteopontin (OPN), a multifunctional protein involved in the modulation of inflammatory processes, may contribute to the development of atherosclerosis and MetS. Therefore, the aim of the study was the assessment of the correlation between OPN concentration in the peripheral blood and the presence of MetS as well as its particular components in the Ps patients. The study comprised 107 male Ps patients (50 patients with MetS and 57 without MetS) and 38 healthy volunteers (HVs). The concentration of OPN in serum was determined using enzyme-linked immunosorbent assay (ELISA) method. Fasting blood glucose and lipid profile components: total cholesterol (total CHOL), high-density lipoprotein cholesterol (HDL-CHOL), low-density lipoprotein cholesterol (LDL-CHOL), triglycerides (TG) were examined. Ps patients with MetS had significantly higher obesity, systolic blood pressure, TG, CHOL/HDL, LDL/HDL and TG/HDL ratios than Ps patients without MetS. OPN serum concentration was significantly higher in the Ps patients than in the HVs (p = 0.022) but not significantly different between the Ps patients with and without MetS (p = 0.275). OPN serum concentration in Ps patients correlated negatively with total CHOL (p = 0.004) and TG (p = 0.009). OPN is increased in Ps patients and may serve as a biomarker of some lipid abnormalities in them. |
format | Online Article Text |
id | pubmed-7918436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79184362021-03-02 Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients Bartosińska, Joanna Przepiórka-Kosińska, Joanna Sarecka-Hujar, Beata Raczkiewicz, Dorota Kowal, Małgorzata Chyl-Surdacka, Katarzyna Bartosiński, Jarosław Kosiński, Jakub Krasowska, Dorota Chodorowska, Grażyna J Clin Med Article Psoriasis (Ps) is an immune-mediated inflammatory skin disease that is widely associated with the clinical features of metabolic syndrome (MetS), including hypertension, abdominal obesity, insulin resistance, type 2 diabetes and dyslipidemia. Osteopontin (OPN), a multifunctional protein involved in the modulation of inflammatory processes, may contribute to the development of atherosclerosis and MetS. Therefore, the aim of the study was the assessment of the correlation between OPN concentration in the peripheral blood and the presence of MetS as well as its particular components in the Ps patients. The study comprised 107 male Ps patients (50 patients with MetS and 57 without MetS) and 38 healthy volunteers (HVs). The concentration of OPN in serum was determined using enzyme-linked immunosorbent assay (ELISA) method. Fasting blood glucose and lipid profile components: total cholesterol (total CHOL), high-density lipoprotein cholesterol (HDL-CHOL), low-density lipoprotein cholesterol (LDL-CHOL), triglycerides (TG) were examined. Ps patients with MetS had significantly higher obesity, systolic blood pressure, TG, CHOL/HDL, LDL/HDL and TG/HDL ratios than Ps patients without MetS. OPN serum concentration was significantly higher in the Ps patients than in the HVs (p = 0.022) but not significantly different between the Ps patients with and without MetS (p = 0.275). OPN serum concentration in Ps patients correlated negatively with total CHOL (p = 0.004) and TG (p = 0.009). OPN is increased in Ps patients and may serve as a biomarker of some lipid abnormalities in them. MDPI 2021-02-13 /pmc/articles/PMC7918436/ /pubmed/33668559 http://dx.doi.org/10.3390/jcm10040755 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bartosińska, Joanna Przepiórka-Kosińska, Joanna Sarecka-Hujar, Beata Raczkiewicz, Dorota Kowal, Małgorzata Chyl-Surdacka, Katarzyna Bartosiński, Jarosław Kosiński, Jakub Krasowska, Dorota Chodorowska, Grażyna Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients |
title | Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients |
title_full | Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients |
title_fullStr | Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients |
title_full_unstemmed | Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients |
title_short | Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients |
title_sort | osteopontin serum concentration and metabolic syndrome in male psoriatic patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918436/ https://www.ncbi.nlm.nih.gov/pubmed/33668559 http://dx.doi.org/10.3390/jcm10040755 |
work_keys_str_mv | AT bartosinskajoanna osteopontinserumconcentrationandmetabolicsyndromeinmalepsoriaticpatients AT przepiorkakosinskajoanna osteopontinserumconcentrationandmetabolicsyndromeinmalepsoriaticpatients AT sareckahujarbeata osteopontinserumconcentrationandmetabolicsyndromeinmalepsoriaticpatients AT raczkiewiczdorota osteopontinserumconcentrationandmetabolicsyndromeinmalepsoriaticpatients AT kowalmałgorzata osteopontinserumconcentrationandmetabolicsyndromeinmalepsoriaticpatients AT chylsurdackakatarzyna osteopontinserumconcentrationandmetabolicsyndromeinmalepsoriaticpatients AT bartosinskijarosław osteopontinserumconcentrationandmetabolicsyndromeinmalepsoriaticpatients AT kosinskijakub osteopontinserumconcentrationandmetabolicsyndromeinmalepsoriaticpatients AT krasowskadorota osteopontinserumconcentrationandmetabolicsyndromeinmalepsoriaticpatients AT chodorowskagrazyna osteopontinserumconcentrationandmetabolicsyndromeinmalepsoriaticpatients |